UNIGE document Scientific Article
previous document  unige:163835  next document
add to browser collection

Reprogramming of TLR7 signaling enhances antitumor NK and cytotoxic T cell responses

Hotz, Christian
Treinies, Marina
Rötzer, Laurin C
Oberson, Anne
Spagnuolo, Lorenzo
Perdicchio, Maurizio
Spinetti, Thibaud
show hidden authors show all authors [1 - 10]
Published in Oncoimmunology. 2016, vol. 5, no. 11, e1232219
Abstract Toll-like receptor (TLR) 7 agonists are effective in topical application for the immunotherapy of skin cancers, but their performance for the systemic treatment of solid tumors is limited by the development of TLR tolerance. In this study, we describe a novel strategy to overcome TLR tolerance and enhance TLR7-dependent antitumor immune responses through reprogramming of TLR signaling pathways. The sensitivity of TLR7 signaling in dendritic cells (DC) was increased by prior stimulation with the dsRNA poly(I:C) that mimics virally induced immune activation. Timing of the stimulations was important, as sequential stimulation with poly(I:C) and the TLR7 agonist R848 interspaced by 24 h induced higher MAPK and NFkB signaling in DC than the simultaneous application of the same ligands. DC activated by sequential poly(I:C)/R848 stimulation efficiently induced Th1 differentiation and primed NK-cell and cytotoxic T-cell responses. We have developed a treatment regimen taking advantage of TLR7 reprogram-ming that cured over 80% of large immunogenic tumors in mice by the action of NK cells and cytotoxic T cells. These results have direct implications for the use of these clinically established ligands in the immunotherapy of cancer.
Keywords Cancer immunotherapyRIG-I-like receptors agonistsToll-like receptorsDendritic cellsPoly(I:C)
PMID: 27999742
PMCID: PMC5139637
Full text
Research group Immunopharmacologie du cancer
Swiss National Science Foundation: 31003A_138284
Swiss National Science Foundation: 310030_156372
Swiss National Science Foundation: PDFMP3_137079
(ISO format)
HOTZ, Christian et al. Reprogramming of TLR7 signaling enhances antitumor NK and cytotoxic T cell responses. In: Oncoimmunology, 2016, vol. 5, n° 11, p. e1232219. doi: 10.1080/2162402X.2016.1232219 https://archive-ouverte.unige.ch/unige:163835

24 hits



Deposited on : 2022-10-03

Export document
Format :
Citation style :